Prevalence of Chronic Kidney Disease Among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Pakistan
DOI:
https://doi.org/10.53350/pjmhs02025197.4Keywords:
Chronic kidney disease, Diabetes mellitus, Albuminuria, Prevalence, Pakistan, Kidney functionAbstract
Background: chronic kidney disease (CKD) is one of the most serious complications of type 2 diabetes mellitus (T2DM). Pakistan, with one of the highest global burdens of diabetes, faces an increasing prevalence of diabetic kidney disease, yet data remain scarce. Early detection using estimated glomerular filtration rate (eGFR) and urine albumin–creatinine ratio (ACR) is essential for timely intervention.
Objectives: To determine the prevalence and stages of CKD among T2DM patients in Pakistan and to identify associated demographic and clinical risk factors.
Methods: This cross-sectional study was conducted at Sargodha Medical College, Sargodha and The University of Lahore Teaching Hospital, Lahore from June 2024 to February 2025. A total of 70 adults with T2DM were enrolled consecutively. Demographics, comorbidities, and treatment history were recorded. Serum creatinine was measured to calculate eGFR using the CKD-EPI 2021 equation, and urine ACR was assessed to detect albuminuria. CKD was defined according to KDIGO 2024 criteria as eGFR <60 mL/min/1.73 m² and/or ACR ≥30 mg/g, with chronicity confirmed through past results or repeat testing.
Results: The mean age of participants was 55.7 ± 10.8 years, with 54.3% males. The mean diabetes duration was 9.2 years, and 65.7% had hypertension. Poor glycemic control (HbA1c ≥8%) was observed in 55.7%. Overall, 31.4% (22/70) had CKD. Among them, 8 were in stage G3a, 6 in G3b, and 3 in G4, while 17 patients (24.3%) had albuminuria (10 in A2, 7 in A3). CKD was more frequent in older patients, those with longer diabetes duration, hypertension, and poor glycemic control.
Conclusion: CKD affects nearly one-third of diabetic patients in Pakistan, with many cases detectable only through albuminuria screening. Routine use of both eGFR and ACR, alongside aggressive management of blood pressure and glycemia, and broader access to renoprotective therapies are essential to reduce the burden of diabetic kidney disease.
References
Khan A, Cheema MF, Fatima R, Cheema SS, Butt Z, Gillani S, et al. Prevalence of chronic kidney disease in a high-risk population in urban Lahore, Pakistan: a cross-sectional study. Cureus. 2024 Jun 27;16(6):e63296. doi:10.7759/cureus.63296.
Munir A, Gulzar S, Afzal A, Zahid MA, Khan MA, Khan NUH, et al. Prevalence of diabetic nephropathy among patients of type 2 diabetes at tertiary care hospital Lahore. J Health Rehabil Res. 2024;4(2):1607–11. doi:10.61919/jhrr.v4i2.1108.
Aregawi K, et al. Prevalence of chronic kidney disease and associated factors among adult diabetic patients: a cross-sectional study. Front Epidemiol. 2024; (9):1467911. doi:10.3389/fepid.2024.1467911.
Jairoun AA, et al. Predictors of chronic kidney disease survival in type 2 diabetics: insights from UAE. Sci Rep. 2024;14: (article 58574). doi:10.1038/s41598-024-58574-X.
Raza MH, Bhutta ME, Siddique MH. Enhancing early detection of diabetic kidney disease: integrating multiparametric approach and machine learning models. Int J Diabetes Dev Ctries. 2025; (online ahead of print). doi:10.1007/s13410-025-01474-1.
Haroon A, Riaz M, Rabbani B, Saeed A. Safety of fasting in diabetic and non-diabetic patients with stable chronic kidney disease during Ramadan. Pak J Med Sci. 2024;40(4):563–7. doi:10.12669/pjms.40.4.7989.
Sardar MB, Ahmed S, Ashraf H, Ashfaq H, Nadeem ZA, Babar M, et al. Temporal and regional trends in adults with diabetic kidney disease in the US from 1999 to 2020. Diabetes Res Clin Pract. 2024 Jul;213:111729. doi:10.1016/j.diabres.2024.111729.
Wan KS, Hairi NN, Mustapha F, et al. Prevalence of diabetic kidney disease and associated factors among patients with type 2 diabetes in a multi-ethnic Asian country. Sci Rep. 2024;14:7074. doi:10.1038/s41598-024-57723-6.
Ijaz K, et al. Prevalence of CKD among patients with diabetes and hypertension in [region]. AMRJ. 2025; (in press).
Ali A, et al. Prevalence and risk factors of diabetic nephropathy in T2DM patients in Pakistan. GJMS. 2023; (online). [No DOI]
Jabbar A, Rahman AU, Khan AW, et al. Identifying risk factors associated with diabetic kidney disease in type 2 diabetics: a single-center study. J Popul Ther Clin Pharmacol. 2024;31(6):445–51. doi:10.53555/jptcp.v31i6.6520.
Almomani EY, et al. The rising burden of chronic kidney diseases in patients with diabetes: a regional analysis. BMC Biotechnol Appl Sci. 2023; (online). doi:10.1186/s43088-023-00428-y.
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12:7–11. [DOI not provided]
Duan JY, Duan GC, Wang CJ, et al. Prevalence and risk factors of CKD and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 2020 Apr 3;21(1):115. doi:10.1186/s12882-020-01761-5.
Gummidi B, John O, Ghosh A, et al. A systemic study of the prevalence and risk factors of CKD in Uddanam, India. Kidney Int Rep. 2020;5:2246–55. doi:10.1016/j.ekir.2020.08.012.
Global Burden of Disease Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease attributable to high body mass index among 20-54 years old, 1990–2021. ArXiv. 2025 Jul. doi:10.48550/arXiv.2507.23537.
Khan J, et al. The increasing rate of diabetes in Pakistan: a silent killer. Ann Med Surg (Lond). 2022;79:103902. doi:10.1016/j.amsu.2022.103902.
Bhutta Z, et al. Diabetes in Pakistan: addressing the crisis. Lancet Diabetes Endocrinol. 2022;10(5):247–8. doi:10.1016/S2213-8587(22)00058-8.
Asif M, Aslam M, Altaf S, Atif S, Majid A. Prevalence and sociodemographic factors of overweight and obesity among Pakistani adults. J Obes Metab Syndr. 2020 Mar;29(1):38–45. doi:10.7570/jomes20031.
Global Burden of Disease Collaboration. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: systematic analysis for Global Burden of Disease Study 2015. Lancet. 2020;395(10225):709–33. doi:10.1016/S0140-6736(19)62012-4.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 AYESHA TARIQ, MALAIKA YOUNAS, FILZA NAWAZISH, RIMSHA SADAF, MAAZ HAMAD, HAFIZ HAMMAD ABDULLAH
This work is licensed under a Creative Commons Attribution 4.0 International License.
